The Clinical Relevance and Functional Implications of Thymosin Beta-10 in Glioma

Table 1

Correlations between TMSB10 level and characteristics of glioma patients.

Characteristics	Low expression of TMSB10	High expression of TMSB10	value
n	349	350
Age, n (%)			<0.001
≤60 yrs	319 (45.6%)	237 (33.9%)
>60 yrs	30 (4.3%)	113 (16.2%)
Gender, n (%)			0.234
Female	141 (20.2%)	157 (22.5%)
Male	208 (29.8%)	193 (27.6%)
IDH status, n (%)			<0.001
WT	20 (2.9%)	226 (32.8%)
Mut	326 (47.3%)	117 (17%)
1p/19q codeletion, n (%)			<0.001
Noncodel	199 (28.8%)	321 (46.4%)
Codel	150 (21.7%)	22 (3.2%)
WHO grade, n (%)			<0.001
G2	168 (26.4%)	56 (8.8%)
G3	134 (21%)	111 (17.4%)
G4	2 (0.3%)	166 (26.1%)